Erratum to 'FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?': [ESMO Open Volume 5, Issue 5, 2020, e000633]

Publication

Erratum to 'FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?': [ESMO Open Volume 5, Issue 5, 2020, e000633]

Lamarca, Angela
;
Foster, L.
;
Satyadas, T.
;
Siriwardena, A
;
Valle, Juan W

Abstract

None

Authors

Lamarca, Angela
Foster, L.
Satyadas, T.
Siriwardena, A
Valle, Juan W

Affiliation

Department of Medical Oncology, The Christie NHS Foundation Trust/Division of Cancer Sciences, University of Manchester, Manchester, UK.

Date

2021

Collections

All Christie Publications

Show all metadata

Files

Adobe PDF, 130.72 KB

Type

Other

Citation

Lamarca A, Foster L, Satyadas T, Siriwardena A, Valle JW. Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’ ESMO Open . 2021 Jun;6(3):100138.

URI

http://hdl.handle.net/10541/624245